got for no_老虎社区_美港股上老虎

Wins888
2021-10-07

got for novavax

Here's Why Moderna Stock Dropped Wednesday

The vaccine maker could lose a key portion of its addressable market. What happened Shares of Moder

Here's Why Moderna Stock Dropped Wednesday

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":823110409,"tweetId":"823110409","gmtCreate":1633597438646,"gmtModify":1633597438854,"author":{"id":3573623994106312,"idStr":"3573623994106312","authorId":3573623994106312,"authorIdStr":"3573623994106312","name":"Wins888","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":4,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":9,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>got for novavax</p></body></html>","htmlText":"<html><head></head><body><p>got for novavax</p></body></html>","text":"got for novavax","highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/823110409","repostId":1151077760,"repostType":4,"repost":{"id":"1151077760","kind":"news","pubTimestamp":1633597276,"share":"https://www.laohu8.com/m/news/1151077760?lang=&edition=full","pubTime":"2021-10-07 17:01","market":"us","language":"en","title":"Here's Why Moderna Stock Dropped Wednesday","url":"https://stock-news.laohu8.com/highlight/detail?id=1151077760","media":"Motley Fool","summary":"The vaccine maker could lose a key portion of its addressable market.\n\nWhat happened\nShares of Moder","content":"<blockquote>\n <b>The vaccine maker could lose a key portion of its addressable market.</b>\n</blockquote>\n<p><b>What happened</b></p>\n<p>Shares of&nbsp;<b><a href=\"https://laohu8.com/S/MRNA\">Moderna, Inc.</a>&nbsp;</b>fell 9% on Wednesday after Scandinavian health officials said they would take action to limit the use of the drugmaker's COVID-19 vaccine in children and young adults.</p>\n<p><b>So what</b></p>\n<p>The Swedish health agency will hold off giving Moderna's drug to people under 30 years old after preliminary data from a not-yet-published study showed a potential higher risk of heart inflammation in those who received the vaccine. \"The connection is especially clear when it comes to Moderna's vaccine Spikevax, especially after the second dose,\" the agency said. Swedish health officials did, however, note that the condition was very rare.</p>\n<p>Denmark will likewise suspend the administration of Moderna's vaccine in kids aged 12 to 17.</p>\n<p>In its place, the two countries will recommend<b>Pfizer</b>&nbsp;(NYSE:PFE)and<b>BioNTech</b>'s(NASDAQ:BNTX)COVID-19 vaccine. Additionally, Norway reiterated its recommendation that children and young men use Pfizer and BioNTech's drug due to side effects from Moderna that appear to be more prevalent in young males:</p>\n<p>\"Men under the age of 30 should also consider choosing Cominarty when they get vaccinated,\" Norwegian health official Geir Bukholm said.</p>\n<p><b>Now what</b></p>\n<p>It's not good news when medical professionals recommend a rival's drug in place of your own. But Moderna'sinvestorsshould note that more data from the aforementioned Nordic study is expected in the coming month. The European Medicines Agency (EMA) will review the data to see if additional -- or, perhaps, fewer -- precautions are warranted.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Here's Why Moderna Stock Dropped Wednesday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHere's Why Moderna Stock Dropped Wednesday\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-07 17:01 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/06/heres-why-moderna-stock-dropped-today/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The vaccine maker could lose a key portion of its addressable market.\n\nWhat happened\nShares of Moderna, Inc. fell 9% on Wednesday after Scandinavian health officials said they would take action to ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/06/heres-why-moderna-stock-dropped-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MRNA":"Moderna, Inc."},"source_url":"https://www.fool.com/investing/2021/10/06/heres-why-moderna-stock-dropped-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1151077760","content_text":"The vaccine maker could lose a key portion of its addressable market.\n\nWhat happened\nShares of Moderna, Inc. fell 9% on Wednesday after Scandinavian health officials said they would take action to limit the use of the drugmaker's COVID-19 vaccine in children and young adults.\nSo what\nThe Swedish health agency will hold off giving Moderna's drug to people under 30 years old after preliminary data from a not-yet-published study showed a potential higher risk of heart inflammation in those who received the vaccine. \"The connection is especially clear when it comes to Moderna's vaccine Spikevax, especially after the second dose,\" the agency said. Swedish health officials did, however, note that the condition was very rare.\nDenmark will likewise suspend the administration of Moderna's vaccine in kids aged 12 to 17.\nIn its place, the two countries will recommendPfizer (NYSE:PFE)andBioNTech's(NASDAQ:BNTX)COVID-19 vaccine. Additionally, Norway reiterated its recommendation that children and young men use Pfizer and BioNTech's drug due to side effects from Moderna that appear to be more prevalent in young males:\n\"Men under the age of 30 should also consider choosing Cominarty when they get vaccinated,\" Norwegian health official Geir Bukholm said.\nNow what\nIt's not good news when medical professionals recommend a rival's drug in place of your own. But Moderna'sinvestorsshould note that more data from the aforementioned Nordic study is expected in the coming month. The European Medicines Agency (EMA) will review the data to see if additional -- or, perhaps, fewer -- precautions are warranted.","news_type":1,"symbols_score_info":{"MRNA":0.9}},"isVote":1,"tweetType":1,"viewCount":1577,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":13,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}